Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A
Open Access
- 13 October 2009
- journal article
- Published by Springer Science and Business Media LLC in Retrovirology
- Vol. 6 (1), 90
- https://doi.org/10.1186/1742-4690-6-90
Abstract
Eukaryotic translation initiation factor eIF5A has been implicated in HIV-1 replication. This protein contains the apparently unique amino acid hypusine that is formed by the post-translational modification of a lysine residue catalyzed by deoxyhypusine synthase and deoxyhypusine hydroxylase (DOHH). DOHH activity is inhibited by two clinically used drugs, the topical fungicide ciclopirox and the systemic medicinal iron chelator deferiprone. Deferiprone has been reported to inhibit HIV-1 replication in tissue culture. Ciclopirox and deferiprone blocked HIV-1 replication in PBMCs. To examine the underlying mechanisms, we investigated the action of the drugs on eIF5A modification and HIV-1 gene expression in model systems. At early times after drug exposure, both drugs inhibited substrate binding to DOHH and prevented the formation of mature eIF5A. Viral gene expression from HIV-1 molecular clones was suppressed at the RNA level independently of all viral genes. The inhibition was specific for the viral promoter and occurred at the level of HIV-1 transcription initiation. Partial knockdown of eIF5A-1 by siRNA led to inhibition of HIV-1 gene expression that was non-additive with drug action. These data support the importance of eIF5A and hypusine formation in HIV-1 gene expression. At clinically relevant concentrations, two widely used drugs blocked HIV-1 replication ex vivo. They specifically inhibited expression from the HIV-1 promoter at the level of transcription initiation. Both drugs interfered with the hydroxylation step in the hypusine modification of eIF5A. These results have profound implications for the potential therapeutic use of these drugs as antiretrovirals and for the development of optimized analogs.Keywords
This publication has 95 references indexed in Scilit:
- The Drosophila deoxyhypusine hydroxylase homologue nero and its target eIF5A are required for cell growth and the regulation of autophagyThe Journal of cell biology, 2009
- Hypusine-containing protein eIF5A promotes translation elongationNature, 2009
- Hypusine modification for growth is the major function of spermidine in Saccharomyces cerevisiae polyamine auxotrophs grown in limiting spermidineProceedings of the National Academy of Sciences of the United States of America, 2008
- Mutational analyses of human eIF5A-1 - identification of amino acid residues critical for eIF5A activity and hypusine modificationThe FEBS Journal, 2007
- Iron chelators ICL670 and 311 inhibit HIV-1 transcriptionVirology, 2007
- Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modificationAmino Acids, 2007
- Neuronal growth and survival mediated by eIF5A, a polyamine-modified translation initiation factorProceedings of the National Academy of Sciences of the United States of America, 2007
- Specificity of the Deoxyhypusine Hydroxylase-Eukaryotic Translation Initiation Factor (eIF5A) InteractionPublished by Elsevier BV ,2007
- eIF5A binds to translational machinery components and affects translation in yeastBiochemical and Biophysical Research Communications, 2006
- The active site of deoxyhypusyl hydroxylase: use of catecholpeptides and their component chelator and peptide moieties as molecular probesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991